Linked Data API

Show Search Form

Search Results

1433433
registered interest false more like this
date less than 2022-02-21more like thismore than 2022-02-21
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Tixagevimab/cilgavimab more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government how much Evusheld monoclonal antibody treatment they have secured; and when this treatment will be available to the clinically vulnerable in the UK. more like this
tabling member printed
Lord Mendelsohn more like this
uin HL6287 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-02-28more like thismore than 2022-02-28
answer text <p>Evusheld is not currently authorised for use in the United Kingdom. We continue to monitor a range of products, including Evusheld. However, we are unable to provide information on negotiations with companies as this is commercially sensitive.</p><p>On 5 October 2021, the Department invited suppliers to submit an expression of interest on neutralising antibody treatments being developed for treating and preventing COVID-19. This will enable the Department to undertake fair and transparent market engagement with suppliers.</p> more like this
answering member printed Lord Kamall more like this
question first answered
less than 2022-02-28T17:26:48.933Zmore like thismore than 2022-02-28T17:26:48.933Z
answering member
4909
label Biography information for Lord Kamall more like this
tabling member
4286
label Biography information for Lord Mendelsohn more like this